Jazz Pharmaceuticals
JAZZ
230.26
-6.19
-2.62%
Jazz Pharmaceuticals
US · JAZZ
#1123 by market cap
Listed 1970
230.26
-6.19
-2.62%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Jazz Pharmaceuticals
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
- Founded
- 2005
- CEO
- Ms. Renee D. Gala
- Employees
- 2,890
- Headquarters
- Dublin, Dublin, Ireland
- Fiscal year end
- 12-31
- Website
- jazzpharma.com
Company profile
- Exchange
- US
- Symbol
- JAZZ
- Market-cap rank
- #1123
- Listing date
- 1970-01-01
- Market cap
- 14.78B
- Float cap
- 14.33B
- Shares out
- 64.19M
- Float shares
- 62.25M
Sectors & themes
Quote time 2026-11-20 20:02:26 · For reference only, not investment advice and not tailored to your situation.
Jazz Pharmaceuticals discussion 0 comments